Evidence map›Paper›PMID 41121568›Full record

ArticleClinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery2026

The Bonebridge Active Bone Conduction Hearing Implant: Safety, Effectiveness and Outcomes Based on 355 Patients.

Piotr Henryk Skarzynski, Katarzyna Beata Cywka, Emilia Anna Czaplicka, Henryk Skarzynski

Abstract read
In one paragraph

Article in Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. The Bonebridge Active Bone Conduction Hearing Implant: Safety, Effectiveness and Outcomes Based on 355 Patients.Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Piotr Henryk SkarzynskiTeleaudiology and Screening Department, World Hearing Center, Institute of Physiology and Pathology of Hearing, Warsaw, Poland.ORCID 0000-0002-4978-1915
Katarzyna Beata CywkaOtorhinolaryngosurgery Clinic, World Hearing Center, Institute of Physiology and Pathology of Hearing, Warsaw, Poland.ORCID 0000-0003-1224-1074
Emilia Anna CzaplickaTeleaudiology and Screening Department, World Hearing Center, Institute of Physiology and Pathology of Hearing, Warsaw, Poland.ORCID 0009-0007-9221-2105
Henryk SkarzynskiOtorhinolaryngosurgery Clinic, World Hearing Center, Institute of Physiology and Pathology of Hearing, Warsaw, Poland.ORCID 0000-0001-7141-9851

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis study evaluates the safety and efficacy of the Bonebridge BCI 601 and 602 bone conduction implants in our largest cohort to date of 355 patients. The patients had a wide age range and exhibited conductive, mixed, or single-sided deafness (SSD).

designAll patients underwent Bonebridge implantation. Pre- and post-implantation evaluations included pure-tone audiometry, speech recognition tests, and free-field audiometry. Word recognition was measured using the Polish Monosyllabic Word Test, while speech reception in noise was assessed using the Polish Sentence Matrix Test. Subjective benefit was assessed using the APHAB questionnaire. Follow-up tests were performed 3-6 months after activation.

resultsRevision surgery was required in 17 patients (4.8%) due to complications, including implant removal in 5 cases. Reimplantation was successful in 4 of these. The APHAB questionnaire showed improved hearing function and all hearing tests also showed significant improvement.

conclusionActive bone conduction implantation is an effective method for the rehabilitation of conductive hearing loss, mixed hearing loss, and unilateral deafness. This large cohort study confirms significant hearing improvement and subjective benefits. The low complication rate supports the reliability of the Bonebridge system.

Indexed as

Bone ConductionHearing AidsHearing Loss, ConductiveAdolescentAdultAgedAged, 80 and overAudiometry, Pure-ToneFemaleHumansMaleMiddle AgedProsthesis DesignSpeech PerceptionTreatment OutcomeYoung AdultBonebridge implantationbone conduction implantsconductive hearing losshearing lossmixed hearing losssingle‐sided deafness

Identifiers

PMID41121568
PMCPMC12869012

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.